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C4-aldehyde of guaiazulene: synthesis and
derivatisation†
Georgia E. Williams, a Gabriele Kociok-Köhn, b Tony D. James a,c and
Simon E. Lewis *a
Guaiazulene is an alkyl-substituted azulene available from natural sources and is a much lower cost start-
ing material for the synthesis of azulene derivatives than azulene itself. Here we report an approach for
the selective functionalisation of guaiazulene which takes advantage of the acidity of the protons on the
guaiazulene C4 methyl group. The aldehyde produced by this approach constitutes a building block for
the construction of azulenes substituted on the seven-membered ring. Derivatives of this aldehyde syn-
thesised by alkenylation, reduction and condensation are reported, and the halochromic properties of a
subset of these derivatives have been studied.
Introduction
Azulene (1) is a non-alternant bicyclic aromatic hydrocarbon,
that has significantly different properties to those of its isomer
naphthalene (2).1 Whereas the HOMO–LUMO gap in naphtha-
lene leads to absorption in the UV region, the corresponding
molecular orbitals are closer in energy in azulene, hence
leading to an absorption in the visible region. Thus, naphtha-
lene is colourless but azulene is blue. Azulene also displays
anomalous fluorescence characteristics, being an exception to
Kasha’s rule, with the S2 → S0 transition being the dominant
mode of emission.2 Additional interesting optical properties
such as halochromism,3 solvatochromism4 and barochro-
mism5 have also been reported for certain azulenes. Azulene
also has a dipole moment of 1.08 D, unusually high for a
simple hydrocarbon.6 This arises from the contribution of
resonance structure 1′, in which both individual rings are 6π
aromatic systems (Fig. 1). These notable properties have led to
azulenes being used extensively as both colorimetric7 and fluo-
rescent8 probes for various analytes. Azulenes have also been
employed in solar cells9 and organic electronics,10 as well as in
medicinal chemistry.11
These various applications have been enabled by the devel-
opment of synthetic routes to substituted azulenes.12 One
approach is to synthesise the azulene ring from a precursor
which already incorporates the desired substituents, for
example by aromatisation of 1,1-dicyanodihydroazulenes13 or
by a carbene insertion/ring expansion approach.14 Another
strategy is to employ synthetic methodology that introduces
the desired substituents onto a pre-existing azulene ring.
Approaches for functionalisation of the 5-membered ring of
azulene include SEAr reactions,
15 cross-coupling16 and C–H
activation.17 Approaches for functionalisation of the 7-mem-
bered ring of azulene are less numerous, but include vicarious
nucleophilic substitution18 and nucleophilic addition/
rearomatisation.16g,19 However, regardless of the diversity of
approaches for azulene derivatisation, work in this area is hin-
dered by the high cost of azulene itself – preparation of the
parent hydrocarbon requires multistep procedures and/or
reagents that are themselves costly.15a,20 There is therefore a
motivation to use an alternative azulene starting material
which is abundantly available from natural sources and hence
has a much lower cost, namely guaiazulene (3).
Guaiazulene and its derivatives are sesquiterpene natural
products produced by various organisms, in particular gorgo-
nian octocorals and the fungal genus Lactarius.21 Moreover,
guaiazulene may be produced from the essential oils isolated
from genera such as Eucalyptus,22 Matricaria (chamomile)23
and others.24 These processes proceed via the dehydration/
Fig. 1 Structures of azulene, naphthalene and guaiazulene.
†Electronic supplementary information (ESI) available. CCDC 2047319. For ESI
and crystallographic data in CIF or other electronic format see DOI: 10.1039/
d0ob02567d
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dehydrogenation of other sesquiterpenes such as guaiol and
occur in high yields, permitting the large scale production of
guaiazulene at low cost. The main uses of guaiazulene and its
derivative sodium guaiazulene-3-sulfonate are as anti-inflam-
matory agents and in cosmetics.25
The alkyl groups on guaiazulene do not influence the
azulene chromophore significantly, but they impart a much
lower melting point (30–33 °C)26 and guaiazulene can undergo
very slow decomposition on exposure to air.27 However, deriva-
tives bearing electron withdrawing groups are generally stable.
Methods for derivatisation of guaiazulene are not as exten-
sively developed as for azulene itself and in some instances
may be hindered by the alkyl substituents. On the other hand,
the alkyl substituents of guaiazulene can be seen as handles
for further derivatisation themselves.28 One strategy to achieve
this exploits the known acidity of the protons on the guaiazu-
lene C4 methyl group.3h,17n,29 The low pKa of these protons
arises from the resonance stabilisation of the corresponding
conjugate base, [3–H]− that may be attributed to resonance
structure [3′–H]− (Scheme 1) that comprises an aromatic cyclo-
pentadienide substructure.
Amide acetals such as dimethylformamide dimethyl acetal
(DMFDMA) are versatile reagents able to effect a variety of syn-
thetic transformations.30 Reaction of an amide acetal with aryl
methyl groups to give the corresponding enamines was first
reported by Meerwein31 and was further developed by
Bredereck.32 Oxidative cleavage of such enamines is possible
using sodium periodate (with no requirement for osmium tetr-
oxide).33 Taken together, these two procedures allow formation
of an aryl aldehyde in two steps from the corresponding aryl
methyl group. The reaction mechanism requires that the arene
is able to stabilise a benzylic anion, hence electron-poor arene
substrates are generally required (Scheme 2a). We reasoned
that this synthetic sequence could be applicable to guaiazu-
lene, resulting in a regioselective transformation of the
C4 methyl group to an aldehyde, although whether the
C4 methyl protons were sufficiently acidic was unclear at the
outset. To our knowledge there are three prior reports of azule-
nyl aldehydes being formed from the corresponding azulene
methyl groups in this way. In 2006, Kim, Osuka and co-
workers reported the reaction of a 4-methylazulene 4, bearing
an electron-withdrawing ester at the 1-position, which would
lower the pKa of the C4 methyl protons (Scheme 2b).
34 In 2015,
Leino and co-workers reported the reaction of 6-methylazulene
6, which lacks any other substituents (Scheme 2c).35 Most
recently, in 2018 Shoji and co-workers reported the reaction of
various 2-methylazulenes of type 8, finding that the reaction
did not proceed without an electron-withdrawing group at the
1-position (Scheme 2d).36
In this paper we describe the first synthesis of guaiazulene-
4-carbaldehyde, as well as some further transformations of
this compound.
Results and discussion
Treatment of guaiazulene 3 with DMFDMA in DMF gave crude
enamine 10 as a green solid after aqueous workup.‡ This
proved to be somewhat unstable and could not be purified by
chromatography on silica. Thus, 10 was used crude, and was
directly subjected to oxidative cleavage with NaIO4 to give
novel aldehyde 11 in 77% yield over two steps (Scheme 3). In
contrast to 10, aldehyde 11 could be purified by chromato-
graphy on silica, and is stable in pure form. Crystals of 11 were
subjected to X-ray diffraction analysis and the resultant struc-
ture is shown in Fig. 2.
We anticipate that aldehyde 11 may find various uses in
synthesis, since it is accessible in a concise fashion from a
cheap azulenic starting material. Reduction of 11 with NaBH4
furnished alcohol 12 in sufficient purity that chromatography
Scheme 1 Guaiazulene deprotonates preferentially at the C4 methyl
group.
Scheme 2 (a) Mechanism for transformation of aryl methyl group to
aryl aldehyde. (b) Work of Kim, Osuka and co-workers. (c) Work of Leino
and co-workers. (d) Work of Shoji and co-workers.
Scheme 3 Synthesis of guaiazulene-4-carbaldehyde 11.
‡Although 10 has not been reported previously, various substituted analogues
have been described, having been formed under Vilsmeier conditions – see ref.
41.
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was not required (Scheme 4a). Alkenylation of 11 by Horner–
Wadsworth–Emmons reaction was carried out using a variety
of phosphonates (Scheme 4b, Table 1).37 Alkenes 20 and 21
were synthesised from phosphonate reagents containing
additional Lewis basic groups, and as such the modified
Masamune–Rousch reaction conditions were employed in
these instances.38
C4-alkenylated guaiazulene derivatives such as 14–22 have
been reported previously,3h,11j,29c,j,29l–n,29r although in these
cases the C4 methyl carbon reacted as a nucleophile, as
opposed to as an electrophile as is the case here. A notable
property of certain C4-alkenylated guaiazulenes described pre-
viously is their halochromism.3h,29c Accordingly, selected alke-
nylated derivatives of 11 and their response to Brønsted acid
were studied. 4-Fluorostyrylazulene 19 was titrated against
increasing quantities of trifluoroacetic acid in CH2Cl2 and UV/
vis absorption spectra were acquired (Fig. 3).
The absorption maxima at λ = 289 nm and λ = 319 nm
decreased in intensity with increasing acid concentration,
whereas a new absorption maximum at λ = 447 nm (in the
blue region) was seen to increase in intensity; an isosbestic
point was observed at λ ≈ 388 nm. 1H-NMR spectra of 19 in
CDCl3 and in CDCl3/TFA were acquired (Fig. 4), and show the
site of protonation to be the guaiazulene C3 position.
Specifically, for the spectrum in CDCl3, the H-3 resonance is
observed as a 1H doublet at 7.46 ppm, whereas in TFA/CDCl3
it is observed as a 2H broad singlet at 4.08 ppm, this chemical
shift being indicative of an sp3-hybridised carbon. Further
support for the guaiazulene C3 position being the site
of protonation comes from comparison with spectra of similar
azulenium cations generated by hydride abstraction from
dihydroazulenes.13d,39
Cyano-substituted 15, chloro-substituted 18 and
α,β-unsaturated ester 20 were investigated in a similar fashion,
and all were observed by NMR to undergo protonation at the
same position (Fig. S1–S3†). Whereas 15 and 18 exhibited
similar maxima and isosbestic points to 19 (Fig. S4 and S5†),
the isosbestic point for 20 was blue shifted (Fig. S6†). As a
further demonstration of the scope for functionalisation of 11,
formation of a nitrone was attempted. Azulenyl nitrones are of
Fig. 2 ORTEP representation of the X-ray structure of 11. Ellipsoids are
shown at 50% probability. Hydrogens are shown as spheres of arbitrary
radius. CCDC 2047319.†
Scheme 4 (a) Reduction of 11. (b) Horner–Wadsworth–Emmons reac-
tion of 11.
Table 1 Horner–Wadsworth–Emmons reactions of 11
Entry R Product R′ Methoda,b Yield (%)
1 14 Et A 38
2 15 Et A 46
3 16 Et A 18
4 17 Et A 56
5 18 Et A 42
6 19 Et A 44
7 20 Me B 41
8 21 Et B 33
9 22 Et A 50
aMethod A: 60% NaH (2 eq.), THF, rt, 2 h. bMethod B: LiCl (3 eq.),
DBU (3 eq.), THF, 0 °C, 3 h.
Fig. 3 Titration of 19 (0.08 mM) with TFA (1 M in CH2Cl2) in CH2Cl2.
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interest as free radical spin traps with neuroprotective activity
and potential clinical utility.40 In the present case, conden-
sation of 11 with N-tert-butylhydroxylamine gave nitrone 23
(Scheme 5).
Conclusions
We have described the concise synthesis of an azulene bearing
an aldehyde at the 4-position (11). The use of a low-cost, com-
mercially available azulene starting material and the require-
ment for only one purification step render 11 an attractive
building block for the synthesis of more complex azulenes
bearing substituents at the 4-position. We have demonstrated




Reactions which required the use of anhydrous, inert atmo-
sphere techniques were carried out under an atmosphere of
argon. Reaction solvents were obtained by passing though
anhydrous alumina columns using an Innovative Technology
Inc. PS-400-7 solvent purification system. In most cases, sol-
vents were purchased as “anhydrous” grade from Fisher
Scientific. “Petrol” refers to petroleum spirit b.pt. 40–60 °C.
TLC was performed using aluminium backed plates pre-coated
with Alugram®SIL G/UV 254 nm. Where needed, visualisation
was accomplished by UV light and/or KMnO4 or using phos-
phomolybdic acid (PMA) dip followed by gentle warming.
Following work up, the organic layers were routinely dried
using anhydrous MgSO4 and evaporated using a Büchi rotary
evaporator. When necessary, further drying was facilitated by
high vacuum. During purification, flash column chromato-
graphy was carried out using 60 angstroms (Å) silica gel
(40–75 micron) purchased from Sigma Aldrich. 1H and 13C
NMR spectra were acquired on Agilent ProPulse 500 MHz or
Bruker Advance 250, 300, 400 or 500 megahertz (MHz) instru-
ments at 298 K. All spectra were referenced to residual solvent
peaks; chemical shifts are reported in parts per million (ppm)
relative to residual chloroform (δ = 7.26 ppm, 1H; 77.16 ppm,
13C). All 13C{1H} resonances are singlets, unless stated other-
wise. Coupling constants, J, reported in Hz, were calculated
using MestreNova 9.0 to the nearest 0.1 Hz. The following
abbreviations are used to label the multiplicities: s, singlet; d,
doublet; t, triplet; q, quartet; quin, quintet; sex, sextet; sep,
septet; dd, doublet of doublets; dq, doublet of quartets; td,
triplet of doublets; m, multiplet and br, broad. 1H and 13C{1H}
assignments for novel compounds are corroborated though 2D
(COSY, HSQC, HMBC). Infrared (IR) spectra were recorded on a
PerkinElmer Spectrum 100 ATR-FTIR spectrometer with only
selected absorbances quoted as ν in cm−1. For mass spec-
trometry a microTOF electrospray time-of-flight (ESI-TOF)
mass spectrometer (Bruker Daltonik GmbH, Bremen,
Germany) was used. Data are reported in the form of m/z. The
observed mass and isotope pattern matched the corresponding
theoretical values as calculated from the expected elemental
formula. Melting points (mp) were determined on an Stanford
Research Systems OptiMelt automated capillary melting point
apparatus in open capillary tubes and are uncorrected. X-Ray
intensity data for 11 were collected at 150(2) K on a Rigaku
SuperNova Dual EosS2 single crystal diffractometer using
monochromated Cu-Kα radiation (λ = 1.54184 Å). Unit cell
determination, data collection data reduction and absorption
correction were performed using the CrysAlisPro software
(version 1.171.40.43a, Rigaku Oxford Diffraction, 2019). The
structure was solved with SHELXT and refined by a full-matrix
least-squares procedure based on F2 (SHELXL-2018/3). All non-
hydrogen atoms were refined anisotropically. Hydrogen atoms
were placed onto calculated positions and refined using a
riding model.
7-Isopropyl-1-methylazulene-4-carbaldehyde (11). Under an
atmosphere of nitrogen, guaiazulene (0.32 g, 1.6 mmol, 1.0
eq.) was dissolved in degassed anhydrous DMF (5.0 mL), to
which N,N-dimethylformamide dimethyl acetal (0.43 mL,
3.2 mmol, 2.0 eq.) was added. The reaction was heated to
140 °C and stirred for 9 h, during which the solution turned
from blue to green. The solution was cooled to room tempera-
ture and diluted with ethyl acetate (30 mL). The organic
mixture was washed with water (30 mL) and 5% LiCl(aq) solu-
tion (2 × 30 mL). The organic phase was dried over MgSO4 and
filtered, and the filtrate was concentrated under reduced
pressure to give crude 10, used immediately. Under aerobic
Fig. 4 Top: 1H-NMR spectrum of 19 in CDCl3. Bottom:
1H-NMR spec-
trum of 19 in TFA/CDCl3 1 : 9. Inset: NMR tubes containing 19 in CDCl3
(left) and 19 in TFA/CDCl3 (right).
Scheme 5 Synthesis of nitrone 23.
Organic & Biomolecular Chemistry Paper

























































































conditions, the crude material was re-dissolved in THF/H2O
(30 mL, 1 : 1, v/v), to which NaIO4 (1.0 g, 4.8 mmol, 3.0 eq.) was
added. The solution was stirred room temperature for
2.5 hours, turning from green to blue, then diluted with ethyl
acetate (30 mL). The organic phase was washed with water
(30 mL) and sat. NaHCO3(aq) solution (2 × 30 mL), for which
the initial aqueous extract was orange and the latter extract
was colourless. The organic phase was dried over MgSO4 and
filtered, and the filtrate was concentrated under reduced
pressure. The crude material was purified by silica column
chromatography, eluting with EtOAc/petrol (5 : 95, Rf = 0.50) to
give 7-isopropyl-1-methylazulene-4-carbaldehyde 11 (0.21 g,
62%) as a blue-brown solid. 1H NMR (500 MHz, CDCl3) δ 1.40
(d, J = 6.9 Hz, 6H, –CH(CH̲3)2), 2.71 (s, 3H, C1–CH3), 3.15
(hept, J = 6.9 Hz, 1H, –CH̲(CH3)2), 7.56 (d, J = 10.4 Hz, 1H, C5–
H), 7.63 (dd, J = 10.5, 1.9 Hz, 1H, C6–H), 7.92 (d, J = 3.6 Hz,
1H, C3–H), 8.08 (d, J = 3.7 Hz, 1H, C2–H), 8.25 (d, J = 1.3 Hz,
1H, C8–H), 10.77 (s, 1H, –CHO) ppm. 13C NMR (500 MHz,
(CDCl3) δ 13.0, 24.6, 39.0, 112.4, 123.8, 126.2, 133.9, 134.1,
134.7, 136.2, 141.4, 141.6, 145.1, 195.1 ppm. IR νmax 701, 761,
1682, 2861, 2924, 2955 cm−1. Melting point 81–84 °C. HRMS
(ESI+): calculated for C15H16O [M + H]
+ 213.1274, found
213.1278.
(7-Isopropyl-1-methylazulen-4-yl)methanol (12). To a solu-
tion of 11 (75 mg, 0.3 mmol, 1.0 eq.) in EtOH was added
NaBH4 (27 mg, 0.7 mmol, 2.0 eq.). The solution was stirred for
1 h at rt and was then quenched with water (10 mL) and
extracted with CH2Cl2 (3 × 10 mL), dried over MgSO4 and fil-
tered, then the filtrate was evaporated under reduced pressure
to give (7-isopropyl-1-methylazulen-4-yl)methanol as a tur-
quoise gum (54 mg, 72%). 1H NMR (500 MHz, (CD3)2CO) δ
1.37 (d, J = 6.9 Hz, 6H, –CH(CH ̲3)2), 2.65 (s, 3H, C1–CH3), 3.14
(hept, J = 6.9 Hz, 1H, –CH̲(CH3)2), 4.57 (t, J = 5.8 Hz, 1H, –OH),
5.18 (d, J = 5.3 Hz, 2H, –CH̲2OH), 7.25 (d, J = 3.7 Hz, 1H, C3–
H), 7.52 (d, J = 10.7 Hz, 1H, C5–H), 7.62–7.59 (m, 2H, C2–H,
C6–H), 8.27 (d, J = 2.0 Hz, 1H, C8–H) ppm. 13C NMR
(500 MHz, (CD3)2CO) δ 12.9, 25.0, 39.0, 64.5, 111.3, 121.3,
125.4, 133.9, 135.7, 135.7, 137.2, 138.6, 141.4, 147.4 ppm. IR
νmax 1008, 1386, 2924, 2956, 3316 cm
−1. HRMS (ESI+): calcu-
lated for C15H18O [M + H]
+ 215.1430, found 215.1438.
General procedure A for Horner–Wadsworth–Emmons
reactions
To a stirred solution of 60% NaH (11 mg, 0.3 mmol, 2.0 eq.) in
anhyd. THF (3 mL) was added dropwise a solution of the
required phosphonate (0.3 mmol, 2.0 eq.) in anhyd. THF
(4 mL) under nitrogen. The mixture was stirred for 10 min
after which a solution of 11 (30 mg, 0.1 mmol, 1.0 eq.) in
anhyd. THF (3 mL) was added dropwise. The mixture was
stirred at rt until the starting material was consumed as shown
by TLC (approx. 2 h). The reaction mixture was diluted with
water (10 mL) and extracted with CH2Cl2 (3 × 30 mL). The com-
bined organic fractions were dried over MgSO4 and filtered,
then the filtrate was evaporated under reduced pressure.
Purification was achieved by column chromatography to give
the desired alkenylazulene.
(E)-4-(4-Iodostyryl)-7-isopropyl-1-methylazulene (14). General
procedure A was used with diethyl (4-iodobenzyl)phosphonate
(100 mg) to give the product as a green waxy gum (22 mg,
38%) following purification via column chromatography using
Petrol (100%, Rf 0.50).
1H NMR (500 MHz, (CD3)2CO) δ 1.38 (d,
J = 6.9 Hz, 6H, –CH(CH̲3)2), 2.66 (s, 3H, C1–CH3), 3.15 (hept, J
= 6.9 Hz, 1H, –CH̲(CH3)2), 7.48 (d, J = 16.2 Hz, 1H, C6H4–
CH̲vCH–), 7.58–7.61 (m, 5H, C3–H, C5–H, C6–H, m–I–Ar–H),
7.67 (d, J = 3.9 Hz, 1H, C2–H), 7.80 (d, J = 8.4 Hz, 2H, o–I–Ar–
H), 8.20 (d, J = 16.2 Hz, 1H, C6H4–CHvCH̲–), 8.25 (s, 1H, C8–
H) ppm. 13C NMR (500 MHz, (CD3)2CO) δ 13.1, 24.9, 38.9, 94.2,
113.1, 120.8, 126.7, 130.0, 130.9, 133.7, 133.7, 135.6, 137.5,
137.7, 137.8, 138.0, 138.8, 141.0, 142.1 ppm. IR νmax 763, 950,




General procedure A was used with diethyl (4-cyanobenzyl)
phosphonate (72 mg) to give the product as a green gum
(20 mg, 46%) following purification via column chromato-
graphy using Petrol (100%, Rf 0.40).
1H NMR (500 MHz,
(CD3)2CO) δ 1.38 (d, J = 6.9 Hz, 6H, –CH(CH ̲3)2), 2.66 (s, 3H,
C1–CH3), 3.16 (hept, J = 6.9 Hz, 1H, –CH̲(CH3)2), 7.59 (d, J =
15.9 Hz, 1H, C6H4–CH̲vCH–), 7.59–7.60 (m, 2H, C5–H, C6–H),
7.63 (d, J = 3.9 Hz, 1H, C3–H), 7.70 (d, J = 3.9 Hz, 1H, C2–H),
7.81 (d, J = 8.4 Hz, 2H, m–CN–Ar–H), 7.98 (d, J = 8.3 Hz, 2H, o–
CN–Ar–H), 8.28 (s, 1H, C8–H), 8.33 (d, J = 16.3 Hz, 1H, C6H4–
CHvCH̲–) ppm. 13C NMR (500 MHz, (CD3)2CO) δ 13.0, 24.9,
38.9, 112.1, 113.2, 119.4, 120.8, 126.8, 128.7, 133.0, 133.4,
133.7, 133.9, 135.7, 137.7, 138.1, 138.2, 141.4, 141.6,
142.7 ppm. IR νmax 738, 787, 1262, 2222, 2849, 2917,




procedure A was used with diethyl (4-nitrobenzyl)phosphonate
(77 mg) to give the product as a dark green waxy gum (8.6 mg,
18%) following purification via column chromatography using
Petrol (100%, Rf 0.40).
1H NMR (500 MHz, CDCl3) δ 1.40 (d, J =
6.9 Hz, 6H, –CH(CH ̲3)2), 2.70 (s, 3H, C1–CH3), 3.13 (hept, J =
6.9 Hz, 1H, –CH̲(CH3)2), 7.40 (d, J = 16.2 Hz, 1H, C6H4–
CH̲vCH–), 7.43 (d, J = 10.9 Hz, 1H, C5–H), 7.45 (br s, 1H, C3–
H), 7.54 (dd, J = 10.9, 1.9 Hz, C6–H), 7.72 (s, 1H, C2–H),
7.74–7.77 (m, 2H, m–NO2–Ar–H), 8.15 (d, J = 16.2 Hz, 1H,
C6H4–CHvCH̲–), 8.23 (d, J = 1.9 Hz, 1H, C8–H), 8.26–8.30 (m,
2H, o–NO2–Ar–H).
13C NMR (500 MHz, (CD3)2CO) δ 13.0, 24.9,
39.0, 113.2, 120.9, 124.8, 126.9, 128.9, 132.6, 133.9, 134.6,
135.7, 137.7, 138.2, 138.3, 141.4, 141.6, 144.8, 148.2 ppm. IR
νmax 744, 1335, 1511, 1592, 2924, 2957 cm
−1. HRMS (ESI+):
calc. for C22H21NO2 [M + H]
+ 332.1645, found 332.1653.
(E)-7-Isopropyl-1-methyl-4-(4-(trifluoromethyl)styryl)azulene
(17). General procedure A was used with (4-(trifluoromethyl)
benzyl)phosphonate (74 mg) to give the product as a green
waxy gum (25 mg, 56%) following purification via column
chromatography using Petrol (100%, Rf 0.60).
1H NMR
(500 MHz, (CD3)2CO) δ 1.38 (d, J = 6.9 Hz, 6H, –CH(CH̲3)2),
2.66 (s, 3H, C1–CH3), 3.15 (hept, J = 7.0 Hz, 1H, –CH̲(CH3)2),
7.59 (d, J = 16.2 Hz, 1H, C6H4–CH̲vCH–), 7.61–7.60 (m, 2H,
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C5–H, C6–H), 7.62 (d, J = 3.9 Hz, C3–H), 7.69 (d, J = 3.8 Hz, 1H,
C2–H), 7.76 (d, J = 8.1 Hz, 2H, m–CF3–Ar–H), 7.99 (d, J = 7.8
Hz, 2H, o–CF3–Ar–H), 8.27 (s, 1H, C8–H), 8.30 (d, J = 16.2 Hz,
1H, C6H4–CHvCH̲–).
13C NMR (500 MHz, (CD3)2CO) δ 142.2
(q, 4JCF = 1.5 Hz), 141.8, 141.3, 138.1, 138.1, 137.6, 135.7,
133.8, 133.2, 132.9, 130.1 (q, 2JCF = 32.0 Hz), 128.5, 126.8,
126.5 (q, 3JCF = 3.9 Hz), 125.4 (q,
1JCF = 270.9 Hz), 120.9, 113.2,
38.9, 24.9, 13.0 ppm. IR νmax 825, 1065, 1106, 1320, 1413,




procedure A was used with diethyl (4-chlorobenzyl)phospho-
nate (74 mg) to yield a green waxy gum (19 mg, 42%) following
purification via column chromatography using Petrol (100%,
Rf 0.40).
1H NMR (500 MHz, (CD3)2CO) δ 1.38 (d, J = 7.0 Hz,
6H, –CH(CH ̲3)2), 2.66 (s, 3H, C1–CH3), 3.15 (hept, J = 6.8 Hz,
1H, –CH̲(CH3)2), 7.44–7.48 (m, 2H, m–Cl–Ar–H), 7.54 (d, J =
16.2 Hz, 1H, C6H4–CH̲vCH–), 7.59–7.60 (m, 2H, C5–H, C6–H),
7.60–7.62 (m, 1H, C3–H), 7.67–7.68 (m, 1H, C2–H), 7.79–7.84
(m, 2H, o–Cl–Ar–H), 8.19 (d, J = 16.2 Hz, 1H, C6H4–CHvCH̲–),
8.26 (s, 1H, C8–H) ppm. 13C NMR (500 MHz, (CD3)2CO) δ 13.1,
24.9, 38.9, 113.1, 120.7, 126.6, 129.6, 129.7, 130.8, 133.5, 133.7,
134.3, 135.6, 137.1, 137.4, 137.7, 137.8, 141.0, 142.1 ppm. IR
νmax 772, 817, 1011, 1091, 1490, 2923 cm
−1. HRMS (ESI+): calc.
for C22H21Cl [M + H]
+ 321.1405, found 321.1412.
(E)-4-(4-Fluorostyryl)-7-isopropyl-1-methylazulene (19).
General procedure A was used with diethyl (3-fluorobenzyl)
phosphonate (70 mg) to give the product as a green waxy gum
(19 mg, 44%) following purification via column chromato-
graphy using Petrol (100%, Rf 0.30).
1H NMR (500 MHz,
(CD3)2CO) δ 1.38 (d, J = 6.9 Hz, 6H, –CH(CH ̲3)2), 2.66 (s, 3H,
C1–CH3), 3.15 (hept, J = 6.9 Hz, 1H, –CH̲(CH3)2), 7.21 (dd,
3JHH
= 8.8 Hz, 3JHF = 8.8 Hz, 2H, o–F–Ar–H), 7.54 (d, J = 16.2 Hz, 1H,
C6H4–CH̲vCH–), 7.59 (br s, 2H, C5–H, C6–H), 7.60 (d, J = 4.0
Hz, 1H, C3–H), 7.66 (d, J = 4.0 Hz, 1H, C2–H), 7.85 (dd, 3JHH =
8.6 Hz, 4JHF = 5.5 Hz, 2H, m–F–Ar–H), 8.12 (d, J = 16.2 Hz, 1H,
C6H4–CHvCH̲–), 8.26 (s, 1H, C8–H) ppm.
13C NMR (500 MHz,
(CD3)2CO) δ 13.1, 25.0, 38.9, 113.1, 116.5 (d,
2JCF = 21.8 Hz),
120.8, 126.6, 129.9 (d, 5JCF = 2.4 Hz), 130.0 (d,
3JCF = 8.1 Hz),
133.6, 133.7, 134.8 (d, 4JCF = 3.3 Hz), 135.7, 137.4, 137.7, 138.0,
140.9, 142.4, 163.7 (d, 1JCF = 246.5 Hz) ppm. IR νmax 771, 1215,
1505, 2955 cm−1. HRMS (ESI+): calc. for C22H21F [M + H]
+
305.1700, found 305.1706.
General procedure B for Horner–Wadsworth–Emmons
reactions
To the required phosphonate (0.1 mmol, 1.0 eq.) in anhyd.
THF (5 mL) was added 1,8-diazabicyclo[5.4.0]undec-7-ene
(60 µL, 0.4 mmol, 3.0 eq.) and lithium chloride (18 mg,
0.4 mmol, 3.0 eq.) under nitrogen. The mixture was stirred for
5 min after which a solution of 11 (30 mg, 0.1 mmol, 1.0 eq.)
in anhyd. THF (5 mL) was added dropwise. The mixture was
stirred at rt until the starting material was consumed as shown
by TLC (approx. 3 h). The mixture was then quenched with
water (2 mL) and sat. NH4Cl. The mixture was then extracted
with EtOAC (3 × 20 mL) and the combined organic fractions
were washed with water (30 mL) and brine (30 mL), dried over
MgSO4 and filtered, then the filtrate was evaporated under
reduced pressure. Purification was achieved by column chrom-
atography to give the desired alkenylazulene.
Methyl (E)-3-(7-isopropyl-1-methylazulen-4-yl)acrylate (20).
General procedure B was used with methyl 2-(diethoxypho-
sphoryl)acetate (26 mg) to give the product as a green waxy
gum (15 mg, 41%) following purification via column chrom-
atography using Petrol/EtOAc (95 : 5; Rf 0.5).
1H NMR
(400 MHz, CDCl3) δ 1.39 (d, J = 6.9 Hz, 6H, –CH(CH ̲3)2), 2.69 (s,
3H, C1–CH3), 3.11 (hept, J = 6.8 Hz, 1H, –CH̲(CH3)2), 3.87 (s,
3H, –OCH3), 6.65 (d, J = 15.9 Hz, 1H, –CHvCH̲–COOCH3),
7.29 (d, J = 10.8 Hz, 1H, C5–H), 7.46 (d, J = 3.9 Hz, 1H, C3–H),
7.50 (dd, J = 10.8, 2.0 Hz, 1H, C6–H), 7.75 (d, J = 3.3 Hz, 1H,
C2–H), 8.21 (d, J = 1.9 Hz, 1H, C8–H), 8.53 (d, J = 15.9 Hz, 1H,
–CH̲vCH–COOCH3) ppm.
13C NMR (500 MHz, CDCl3) δ 13.1,
24.8, 38.6, 52.1, 112.6, 120.4, 122.8, 126.6, 133.6, 134.9, 137.3,
137.4, 138.4, 138.5, 141.8, 145.9, 167.3 ppm. IR νmax 1018,
1169, 1273, 1718, 2958 cm−1. HRMS (ESI+): calc. for C18H20O2
[M + H]+ 269.1536, found 269.1535.
(E)-3-(7-Isopropyl-1-methylazulen-4-yl)acrylonitrile (21).
General procedure B was used with diethyl (cyanomethyl)phos-
phonate (25 mg) to give the product as a dark green waxy gum
(10 mg, 33%) following purification via column chromato-
graphy using Petrol/EtOAc (80 : 20; Rf 0.6).
1H NMR (500 MHz,
CDCl3) δ 1.38 (d, J = 6.9 Hz, 6H, –CH(CH̲3)2), 2.69 (s, 3H, C1–
CH3), 3.12 (hept, J = 6.8 Hz, 1H, –CH̲(CH3)2), 6.13 (d, J = 16.6
Hz, 1H, –CHvCH̲–CN), 7.15 (d, J = 10.7 Hz, 1H, C5–H), 7.34
(d, J = 3.8 Hz, 1H, C3–H), 7.50 (dd, J = 10.7, 2.0 Hz, 1H, C6–H),
7.78 (d, J = 3.7 Hz, 1H, C2–H), 8.22 (d, J = 1.9 Hz, 1H, C8–H),
8.28 (d, J = 16.7 Hz, 1H, –CH̲vCH–CN) ppm. 13C NMR
(500 MHz, CDCl3) δ 13.1, 24.7, 38.6, 101.3, 112.4, 118.0, 119.4,
127.2, 134.0, 134.8, 136.4, 136.9, 137.9, 139.1, 142.5,
151.9 ppm. IR νmax 721, 787, 918, 976, 1422, 2215, 2959 cm
−1.
HMS (ESI−): calc. for C17H17N [M − H]− 234.1288, found
234.1290.
(E)-3-(7-Isopropyl-1-methylazulen-4-yl)-N-methoxy-N-methyl-
acrylamide (22). General procedure A was used with diethyl (2-
(methoxy(methyl)amino)-2-oxoethyl)phosphonate (68 mg) to
give the product as a light blue waxy gum (28 mg, 50%) follow-
ing purification via column chromatography using Petrol
(100%, Rf 0.3).
1H NMR (500 MHz, (CD3)2CO) δ 1.38 (d, J = 6.9
Hz, 6H, –CH(CH ̲3)2), 2.67 (s, 3H, C1–CH3), 3.16 (hept, J = 6.9
Hz, 1H, –CH̲(CH3)2), 3.30 (s, 3H, CH3), 3.84 (s, 3H, CH3), 7.36
(d, J = 15.7 Hz, 1H, –CHvCH̲–COO–), 7.46 (d, J = 3.9 Hz, 1H,
C3–H), 7.50 (d, J = 10.9 Hz, 1H, C5–H), 7.61 (dd, J = 10.9, 1.9
Hz, 1H, C6–H), 7.74 (d, J = 3.9 Hz, 1H, C2–H), 8.30 (d, J = 1.9
Hz, 1H, C8–H), 8.51 (d, J = 15.7 Hz, 1H, –CH̲vCH–COO–)
ppm. 13C NMR (500 MHz, (CD3)2CO) δ 13.0, 24.9, 32.6 (br),
39.0, 62.4, 113.0, 121.2, 122.5, 127.1, 134.2, 135.7, 138.0, 138.4,
138.8, 140.1, 142.2, 143.7, 166.7 (br) ppm. IR νmax 977, 1001,
1378, 1414, 1652, 2958 cm−1. HRMS (ESI+): calc. for
C19H23NO2 [M + H]
+ 298.1810, found 298.1812.
(Z)-N-tert-Butyl-1-(7-isopropyl-1-methylazulen-4-yl)methan-
imine oxide (23). To aldehyde 11 (70 mg, 0.3 mmol, 1.0 eq.)
was added N-tert-butylhydroxylamine hydrochloride (62 mg,
Organic & Biomolecular Chemistry Paper

























































































0.5 mmol, 1.5 eq.) and pyridine (5 mL) under nitrogen. The
mixture was stirred at 95 °C until all the starting material was
consumed by TLC (3 h). After cooling to rt, the pyridine was
evaporated under reduced pressure. The mixture was diluted
with water (10 mL) and extracted with EtOAc (3 × 30 mL) and
the combined organic fractions were washed with brine and
dried over MgSO4 and filtered. The filtrate was evaporated
under reduced pressure to yield a turquoise/green waxy gum
(64 mg, 69%). 1H NMR (500 MHz, (CDCl3) δ 1.38 (d, J = 6.9 Hz,
6H, –CH(CH̲3)2), 1.71 (s, 9H, C(CH3)3), 2.68 (s, 3H, C1–CH3),
3.12 (hept, J = 6.9 Hz, 1H, –CH̲(CH3)2), 7.18 (d, J = 3.7 Hz, 1H,
C3–H), 7.57 (dd, J = 11.0, 2.0 Hz, 1H, C6–H), 7.67 (d, J = 3.7 Hz,
1H, C2–H), 8.21 (d, J = 1.8 Hz, 1H, C8–H), 8.37 (s, 1H,
–CHvN), 8.85 (d, J = 11.0 Hz, C5–H) ppm. 13C NMR (500 MHz,
(CDCl3) δ 13.1, 24.7, 28.6, 38.7, 72.6, 109.7, 121.5, 125.4, 129.5,
133.5, 134.0, 135.3, 137.1, 137.4, 138.4, 143.3 ppm. IR νmax
766, 1131, 1361, 1537, 2958 cm−1. HRMS (ESI+): calc. for
C19H25NO [M + H]
+ 284.2009, found 284.2019.
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